Drug
VX 121 Tez D Iva
VX 121 Tez D Iva: highest development phase Phase 3, developed by Vertex Pharmaceuticals. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Vertex Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| VX-121/TEZ/D-IVA NCT05444257 | Phase 3 | Cystic Fibrosis |
| VX-121/TEZ/D-IVA NCT05535959 | Phase 1 | Cystic Fibrosis |
Latest
No recent events.
Follow VX 121 Tez D Iva on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.